EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Insights from deep mutational scanning in the context of an emerging pathogen

Melissa J Call iD, Matthew E Call iD, Xinyu Wu iD

Biochemical Society Transactions · 2025

DOI: 10.1042/bst20253033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2025. Verfasst von Melissa J Call und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deep mutational scanning (DMS), a high-throughput method leveraging next-generation sequencing, has been crucial in mapping the functional landscapes of key severe acquired respiratory syndrome-coronavirus 2 (SARS-CoV-2) proteins. By systematically assessing thousands of amino acid changes, DMS provides a framework to understand Angiotensin-converting enzyme 2 (ACE2) binding and immune evasion by the spike protein, mechanisms and drug escape potential of the main and papain-like viral proteases and has highlighted areas of concern in the nucleocapsid protein that may affect most currently available rapid antigen testing kits. Each application has required the design of bespoke assays in eukaryotic (yeast and mammalian) cell models, providing an exemplar for the application of this technique to future pandemics. This minireview examines how DMS has predicted key evolutionary changes in SARS-CoV-2 and affected our understanding of SARS-CoV-2 biology, specifically highlighting their relevance for therapeutics development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2MutationHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

SARS-CoV-2deep mutational scanningmultiplexed assays of variant effectsnucleocapsidspikeviral proteases

Substanzen

Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2spike protein, SARS-CoV-2ACE2 protein, human

Autor:innen und Institutionen

  • The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia.

ORCID-Profile: Melissa J Call, Matthew E Call, Xinyu Wu

Zitieren

APA

Call, M. J., Call, M. E., & Wu, X. (2025). Insights from deep mutational scanning in the context of an emerging pathogen. Biochemical Society Transactions. https://doi.org/10.1042/bst20253033

Vancouver

Call MJ, Call ME, Wu X. Insights from deep mutational scanning in the context of an emerging pathogen. Biochemical Society Transactions. 2025. doi:10.1042/bst20253033

BibTeX
@article{Call2025,
  author = {Call, Melissa J and Call, Matthew E and Wu, Xinyu},
  title = {Insights from deep mutational scanning in the context of an emerging pathogen},
  journal = {Biochemical Society Transactions},
  year = {2025},
  doi = {10.1042/bst20253033}
}
Kostenlos starten →